AxoGen, Inc. provided earnings guidance for the fiscal year 2024. For the year, the company expects revenue to be in the range of $177 million to $181 million, which represents an annual growth rate of approximately 11% to 14%.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.63 USD | +1.69% | +2.00% | -2.93% |
Mar. 08 | Axogen Insider Sold Shares Worth $319,891, According to a Recent SEC Filing | MT |
Mar. 08 | AxoGen, Inc. Announces Executive Changes | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.93% | 290M | |
+8.07% | 219B | |
+6.59% | 183B | |
+11.26% | 133B | |
+26.57% | 108B | |
+13.35% | 52.02B | |
-0.62% | 48.2B | |
-0.93% | 40.37B | |
+11.54% | 39.35B | |
+26.76% | 32.03B |
- Stock Market
- Equities
- AXGN Stock
- News AxoGen, Inc.
- AxoGen, Inc. Provides Earnings Guidance for the Fiscal Year 2024